Skip to content

Psychometric Validation of the Competitive Attention Test

Psychometric Validation of the Competitive Attention Test (CAT) : Simultaneous and Separated Measures of Voluntary and Involuntary Attention

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03942835
Acronym
CAT
Enrollment
26
Registered
2019-05-08
Start date
2020-01-21
Completion date
2021-04-20
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Hyperactivity Disorder

Keywords

Attention Deficit Hyperactivity Disorder, attention, distraction, psychometric test, neuropsychological test validating procedure, psychostimulant

Brief summary

This project aims at validating a new neuropsychological test to measure voluntary and involuntary attention for clinical use to diagnose attentional deficits. This project proposes: * a test-retest procedure in healthy subjects aged from 6 to 90 year-old; * testing in attention deficit hyperactivity disorder (ADHD) patients before psychostimulant treatment; * testing in attention deficit hyperactivity disorder (ADHD) patients before psychostimulant treatment.

Interventions

OTHERexperience 1 : Competitive attention test in healthy participants

Comparison of behavioral measures (reaction times and percentage of correct responses) obtained twice with the CAT test in healthy participants (2 to 6 weeks apart).

OTHERexperience 2 : Competitive attention test in patients with ADHD with no treatment

Behavioral (reaction times and percentage of correct responses) and Electroencephalography (EEG) measures obtained with the CAT test in patients with ADHD with no treatment.

OTHERexperience 3 :Competitive attention test in patients with ADHD with psychostimulant treatment

Behavioral (reaction times and percentage of correct responses) and EEG measures obtained with the CAT test in patients with ADHD before and after psychostimulant treatment.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

healthy major participants: * Age from 18 to 90 year-old * Informed consent to participate in the study * No neurological or psychiatric disorder * No history of neuro-psychiatric disorder or neurodevelopmental type dysphasia, dyslexia, dyspraxia, attention deficit disorder healthy minor participants: * Age from 6 to 17 year-old * Informed consent of parents or guardians for the child's participation in the study * No neurological or psychiatric disorder * No history of neuro-psychiatric disorder or neurodevelopmental type dysphasia, dyslexia, dyspraxia, Attention deficit disorder ADHD minor patients: * Age from 6 to 17 year-old * Informed consent of parents or guardians for the child's participation in the study * ADHD Diagnosis with or without hyperactivity * No psychiatric history other than ADHD. * For Experience 3: treatment in progress.

Exclusion criteria

healthy major participants * Age below 18 or above 90 year-old * unaffiliated or non-beneficiaries of the social security scheme healthy minor participants: * Age below 6 or above 18 year-old * unaffiliated or non-beneficiaries of the social security scheme ADHD minor patients: * Age below 6 or above 18 year-old * unaffiliated or non-beneficiaries of the social security scheme

Design outcomes

Primary

MeasureTime frameDescription
Reaction times in healthy subjects and patients with ADHD.6 weeksReaction times in milliseconds obtained with the CAT test in healthy participants and in patients with ADHD.

Secondary

MeasureTime frameDescription
Percentage of correct responses in healthy subjects and patients with ADHD.6 weeksPercentage of correct responses obtained with the CAT test in healthy participants and in patients with ADHD.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026